skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Current understanding of interactions between nanoparticles and the immune system

Journal Article · · Toxicology and Applied Pharmacology
 [1]
  1. Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213 (United States)

The delivery of drugs, antigens, and imaging agents benefits from using nanotechnology-based carriers. The successful translation of nanoformulations to the clinic involves thorough assessment of their safety profiles, which, among other end-points, includes evaluation of immunotoxicity. The past decade of research focusing on nanoparticle interaction with the immune system has been fruitful in terms of understanding the basics of nanoparticle immunocompatibility, developing a bioanalytical infrastructure to screen for nanoparticle-mediated immune reactions, beginning to uncover the mechanisms of nanoparticle immunotoxicity, and utilizing current knowledge about the structure–activity relationship between nanoparticles' physicochemical properties and their effects on the immune system to guide safe drug delivery. In the present review, we focus on the most prominent pieces of the nanoparticle–immune system puzzle and discuss the achievements, disappointments, and lessons learned over the past 15 years of research on the immunotoxicity of engineered nanomaterials. - Graphical abstract: API — active pharmaceutical ingredient; NP — nanoparticles; PCP — physicochemical properties, CARPA — complement activation-related pseudoallergy, ICH — International Conference on Harmonization. Display Omitted - Highlights: • Achievements, disappointments and lessons learned over past decade are reviewed. • Areas in focus include characterization, immunotoxicity and utility in drug delivery. • Future direction focusing on mechanistic immunotoxicity studies is proposed.

OSTI ID:
22689168
Journal Information:
Toxicology and Applied Pharmacology, Vol. 299; Other Information: Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

Nanomaterials in Biomedicine
Journal Article · Thu Jun 11 00:00:00 EDT 2015 · Soft Nanoscience Letters · OSTI ID:22689168

Editorial: Nanotechnology for natural products
Journal Article · Wed Nov 02 00:00:00 EDT 2022 · Frontiers in Chemistry · OSTI ID:22689168

Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future
Journal Article · Sun May 15 00:00:00 EDT 2016 · Toxicology and Applied Pharmacology · OSTI ID:22689168